[1]
K. . Khan, “Clinical Evaluation of Pioglitazone’s Impact on Insulin Resistance and Blood Pressure in Type 2 Diabetic Patients Undergoing Hemodialysis”, IJMBS, vol. 9, no. 1, pp. 241–246, Jan. 2025.